FAQs

The TrialWire™ Platform doesn’t promote or market any particular trial. It works out who might be eligible for trials on the Platform based on their online activity and location using advanced algorithms – and invites those people onto the Platform. From there they go through the AI-Match screener to find exactly the right study for their medical needs/issues – even healthy volunteers.

So unlike the typical trial advert which has condition/TA, age, medical status and more and a phone number and email – what people see with AI-Match is an invitation to search on the Platform for a study that’s right for them.

We decided very early on that patient privacy is paramount and no amount of security could protect such a database. So instead we chose to find people “in the moment” when they are online searching and commenting, or on social media, or even purchasing medical supplies/equipment on sites like Amazon. This way we find the most motivated and active patients. Also, people’s health status and information on databases can quickly be out of date or not relevant. In addition, increasingly people are not wanting to share their information and health status and be kept on a database that may or may not be secure.

So unlike all other online recruitment companies, we never ask for ID information until we find a study for them, and only so we can send on to their chosen clinic – we are very clear we don’t keep their information which means more people join studies via TrialWire™ Platform.

The TrialWire™ Platform has recruited successfully for 462 trials across the US, APAC and EU.

Our data shows:

• 78% of trial rescue studies are fully recruited within the time allocated.
• 92% of trials that start with TrialWire™ Platform from the beginning recruit successfully on time and budget.

The TrialWire™ Platform can recruit for virtually any TA across all eligibility and exclusion criteria because it is the AI and algorithm process rather than specific medical or clinical experience in each TA.

Each study starts with a patient persona and we collect as much data as possible about the type of people we are targeting. This informs our algorithms and AI-Match screener.

This means we can instantly recruit for rare diseases through to the more common metabolic and dermatological studies.